Overview
About Biolidics
Board of Directors
Key Executive Officer
Oncology
Oncology
Products
Resources And Publications
Request for a Quotation
Investor Relations
IR Home
Reports
Announcements
Stock Information
Email Alerts
Contact
Corporate Office
Careers Opportunity
Personal Data Policy
Whistle Blowing Policy
News
Back
21 Nov 2023
Proposed Subscription Of 98,500,000 New Ordinary Shares In The Issued Share Capital Of The Company
Attachment 1
Locate Us
Contact Us
Enquiry Form
Whatsapp Us